| cellular amino acid metabolic process | GO:0006520 | 103 | 0.229 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.197 | |
| telencephalon development | GO:0021537 | 186 | 0.177 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.177 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.173 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.165 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.165 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.164 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.159 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.155 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.150 | |
| epidermis development | GO:0008544 | 187 | 0.148 | |
| positive regulation of mitochondrial membrane permeability involved in apoptotic process | GO:1902110 | 11 | 0.147 | |
| nephron tubule development | GO:0072080 | 84 | 0.146 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.146 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.144 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.142 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.138 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.135 | |
| mitochondrion organization | GO:0007005 | 134 | 0.134 | |
| ear development | GO:0043583 | 200 | 0.134 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.134 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.133 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.132 | |
| ossification | GO:0001503 | 216 | 0.131 | |
| forebrain development | GO:0030900 | 302 | 0.130 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.126 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.125 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.123 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.123 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.121 | |
| gland development | GO:0048732 | 330 | 0.119 | |
| hindbrain development | GO:0030902 | 128 | 0.116 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.115 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.113 | |
| gtp metabolic process | GO:0046039 | 144 | 0.112 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.111 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.111 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.109 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.109 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.109 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.109 | |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.109 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.109 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.109 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.107 | |
| mitochondrial outer membrane permeabilization involved in programmed cell death | GO:1902686 | 11 | 0.106 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.106 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.104 | |
| fertilization | GO:0009566 | 127 | 0.102 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.102 | |
| metencephalon development | GO:0022037 | 89 | 0.100 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.099 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.098 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.098 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.097 | |
| limb development | GO:0060173 | 166 | 0.097 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.097 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.097 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.095 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.095 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.094 | |
| camera type eye development | GO:0043010 | 266 | 0.094 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.094 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.093 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.093 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.093 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.092 | |
| appendage development | GO:0048736 | 166 | 0.091 | |
| b cell activation | GO:0042113 | 161 | 0.090 | |
| spermatogenesis | GO:0007283 | 284 | 0.090 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.089 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.088 | |
| developmental maturation | GO:0021700 | 193 | 0.088 | |
| limb morphogenesis | GO:0035108 | 149 | 0.086 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.086 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.086 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.086 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.086 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.085 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.085 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.085 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.084 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.083 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.083 | |
| nephron epithelium development | GO:0072009 | 92 | 0.083 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.083 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.082 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.082 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.081 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.081 | |
| amine metabolic process | GO:0009308 | 45 | 0.080 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.079 | |
| regulation of mitochondrion organization | GO:0010821 | 27 | 0.079 | |
| endomembrane system organization | GO:0010256 | 147 | 0.077 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.076 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.076 | |
| kidney development | GO:0001822 | 213 | 0.076 | |
| skin development | GO:0043588 | 220 | 0.076 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.075 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.074 | |
| myotube differentiation | GO:0014902 | 105 | 0.074 | |
| protein localization to membrane | GO:0072657 | 108 | 0.072 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.072 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.072 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.071 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.071 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.070 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.070 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.070 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.070 | |
| male gamete generation | GO:0048232 | 285 | 0.069 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.069 | |
| cellular homeostasis | GO:0019725 | 240 | 0.069 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.068 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.068 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.068 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.067 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.067 | |
| regulation of protein localization | GO:0032880 | 231 | 0.067 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.067 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.067 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.066 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.066 | |
| neuron death | GO:0070997 | 154 | 0.065 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.065 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.065 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.065 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.065 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.065 | |
| urogenital system development | GO:0001655 | 261 | 0.065 | |
| stem cell differentiation | GO:0048863 | 268 | 0.064 | |
| t cell proliferation | GO:0042098 | 120 | 0.064 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.064 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.064 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.064 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.063 | |
| positive regulation of lymphocyte apoptotic process | GO:0070230 | 13 | 0.063 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.062 | |
| gtp catabolic process | GO:0006184 | 143 | 0.062 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.062 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.062 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.062 | |
| membrane organization | GO:0061024 | 245 | 0.061 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.061 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.060 | |
| response to amino acid | GO:0043200 | 37 | 0.060 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.060 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.059 | |
| cell adhesion | GO:0007155 | 329 | 0.059 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.059 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.059 | |
| neural tube development | GO:0021915 | 160 | 0.059 | |
| t cell activation | GO:0042110 | 289 | 0.059 | |
| response to ionizing radiation | GO:0010212 | 42 | 0.058 | |
| regulation of cell migration | GO:0030334 | 219 | 0.058 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.058 | |
| muscle tissue development | GO:0060537 | 308 | 0.058 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.058 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.058 | |
| kidney epithelium development | GO:0072073 | 121 | 0.057 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.057 | |
| apoptotic process involved in mammary gland involution | GO:0060057 | 4 | 0.057 | |
| plasma membrane organization | GO:0007009 | 90 | 0.057 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.057 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.056 | |
| female sex differentiation | GO:0046660 | 84 | 0.056 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.056 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.056 | |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.056 | |
| germ cell development | GO:0007281 | 185 | 0.056 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.056 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.056 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.056 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.055 | |
| dephosphorylation | GO:0016311 | 129 | 0.055 | |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 34 | 0.055 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.054 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.054 | |
| response to acid chemical | GO:0001101 | 111 | 0.054 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.054 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.054 | |
| renal system development | GO:0072001 | 225 | 0.054 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.054 | |
| digestive system development | GO:0055123 | 200 | 0.054 | |
| protein maturation | GO:0051604 | 176 | 0.054 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.053 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.053 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.053 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.053 | |
| angiogenesis | GO:0001525 | 201 | 0.053 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.052 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.052 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.052 | |
| calcium ion transport | GO:0006816 | 159 | 0.051 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.051 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.051 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.051 | |
| sensory perception | GO:0007600 | 245 | 0.050 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.050 | |
| regulation of ossification | GO:0030278 | 112 | 0.050 | |
| regulation of neuron death | GO:1901214 | 134 | 0.050 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.050 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.049 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.049 | |
| tissue homeostasis | GO:0001894 | 115 | 0.049 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.049 | |
| protein processing | GO:0016485 | 163 | 0.049 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.049 | |
| diencephalon development | GO:0021536 | 63 | 0.049 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.049 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.049 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.049 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.048 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.048 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.048 | |
| negative regulation of growth | GO:0045926 | 99 | 0.048 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.048 | |
| zymogen activation | GO:0031638 | 41 | 0.048 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.048 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.047 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.047 | |
| negative regulation of osteoblast proliferation | GO:0033689 | 4 | 0.047 | |
| pallium development | GO:0021543 | 120 | 0.047 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.046 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.046 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.046 | |
| cell division | GO:0051301 | 120 | 0.046 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.046 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.046 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.045 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.045 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.045 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.045 | |
| cerebral cortex development | GO:0021987 | 86 | 0.045 | |
| protein catabolic process | GO:0030163 | 221 | 0.045 | |
| response to starvation | GO:0042594 | 65 | 0.044 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.044 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:2001267 | 4 | 0.044 | |
| positive regulation of apoptotic process involved in morphogenesis | GO:1902339 | 4 | 0.044 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.044 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.044 | |
| spleen development | GO:0048536 | 39 | 0.044 | |
| organ growth | GO:0035265 | 117 | 0.044 | |
| positive regulation of mammary gland involution | GO:1903521 | 4 | 0.043 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.043 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.043 | |
| cell growth | GO:0016049 | 130 | 0.043 | |
| skeletal system development | GO:0001501 | 356 | 0.043 | |
| b cell apoptotic process | GO:0001783 | 19 | 0.043 | |
| cation transport | GO:0006812 | 399 | 0.043 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.042 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.042 | |
| limbic system development | GO:0021761 | 72 | 0.042 | |
| nephron development | GO:0072006 | 109 | 0.042 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.042 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.042 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.042 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.042 | |
| response to oxygen levels | GO:0070482 | 62 | 0.041 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.041 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.041 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.041 | |
| axonogenesis | GO:0007409 | 274 | 0.041 | |
| response to nutrient levels | GO:0031667 | 109 | 0.041 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.041 | |
| b cell differentiation | GO:0030183 | 78 | 0.041 | |
| positive regulation of mitochondrial membrane permeability | GO:0035794 | 12 | 0.040 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.040 | |
| digestive tract development | GO:0048565 | 190 | 0.040 | |
| respiratory system development | GO:0060541 | 190 | 0.040 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.040 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.040 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.040 | |
| respiratory tube development | GO:0030323 | 167 | 0.040 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.040 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.040 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.040 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.040 | |
| oocyte differentiation | GO:0009994 | 35 | 0.039 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.039 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.039 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.039 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.039 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.039 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.039 | |
| muscle cell development | GO:0055001 | 133 | 0.039 | |
| gonad development | GO:0008406 | 141 | 0.039 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.039 | |
| endocrine system development | GO:0035270 | 98 | 0.038 | |
| ovarian follicle development | GO:0001541 | 40 | 0.038 | |
| regulation of release of cytochrome c from mitochondria | GO:0090199 | 11 | 0.038 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.038 | |
| mitochondrial transport | GO:0006839 | 36 | 0.038 | |
| wound healing | GO:0042060 | 157 | 0.038 | |
| cellular response to starvation | GO:0009267 | 57 | 0.038 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.037 | |
| activation of cysteine type endopeptidase activity | GO:0097202 | 27 | 0.037 | |
| cell maturation | GO:0048469 | 127 | 0.037 | |
| cation homeostasis | GO:0055080 | 212 | 0.037 | |
| muscle fiber development | GO:0048747 | 76 | 0.037 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.037 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.037 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.037 | |
| protein ubiquitination | GO:0016567 | 171 | 0.037 | |
| female gonad development | GO:0008585 | 71 | 0.037 | |
| immune effector process | GO:0002252 | 321 | 0.037 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.037 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.037 | |
| renal tubule development | GO:0061326 | 87 | 0.036 | |
| fat cell differentiation | GO:0045444 | 160 | 0.036 | |
| positive regulation of leukocyte apoptotic process | GO:2000108 | 21 | 0.036 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.036 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.036 | |
| neural tube closure | GO:0001843 | 90 | 0.036 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.036 | |
| thymocyte apoptotic process | GO:0070242 | 19 | 0.036 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.036 | |
| viral process | GO:0016032 | 41 | 0.036 | |
| male gonad development | GO:0008584 | 88 | 0.035 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.035 | |
| regulation of cell activation | GO:0050865 | 289 | 0.035 | |
| striated muscle cell development | GO:0055002 | 125 | 0.035 | |
| male sex differentiation | GO:0046661 | 109 | 0.035 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.035 | |
| neuron migration | GO:0001764 | 122 | 0.034 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.034 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.034 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.034 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.034 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.034 | |
| multicellular organism growth | GO:0035264 | 161 | 0.034 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.033 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.033 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.033 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.033 | |
| regulation of mammary gland involution | GO:1903519 | 4 | 0.033 | |
| fear response | GO:0042596 | 33 | 0.033 | |
| ovulation cycle | GO:0042698 | 59 | 0.033 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.033 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.033 | |
| hexose metabolic process | GO:0019318 | 98 | 0.033 | |
| cell junction organization | GO:0034330 | 77 | 0.033 | |
| interleukin 8 production | GO:0032637 | 4 | 0.032 | |
| t cell differentiation | GO:0030217 | 174 | 0.032 | |
| hair follicle development | GO:0001942 | 85 | 0.032 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.032 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.032 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.032 | |
| pigmentation | GO:0043473 | 71 | 0.032 | |
| membrane fusion | GO:0061025 | 38 | 0.032 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.031 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.031 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.031 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.031 | |
| regulation of mitochondrial membrane permeability | GO:0046902 | 17 | 0.031 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.031 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.031 | |
| hair cycle | GO:0042633 | 90 | 0.031 | |
| response to radiation | GO:0009314 | 165 | 0.030 | |
| mesoderm development | GO:0007498 | 100 | 0.030 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.030 | |
| mapk cascade | GO:0000165 | 281 | 0.030 | |
| blastocyst development | GO:0001824 | 80 | 0.030 | |
| protein oligomerization | GO:0051259 | 67 | 0.030 | |
| blood vessel remodeling | GO:0001974 | 33 | 0.030 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.029 | |
| glucose homeostasis | GO:0042593 | 128 | 0.029 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.029 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.029 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.029 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.029 | |
| protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | GO:0001844 | 4 | 0.029 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.029 | |
| myotube cell development | GO:0014904 | 60 | 0.029 | |
| release of sequestered calcium ion into cytosol | GO:0051209 | 42 | 0.029 | |
| positive regulation of neuron death | GO:1901216 | 28 | 0.029 | |
| steroid metabolic process | GO:0008202 | 119 | 0.029 | |
| maintenance of location | GO:0051235 | 89 | 0.028 | |
| glomerulus development | GO:0032835 | 40 | 0.028 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.028 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.028 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.028 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.028 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.028 | |
| ectoderm formation | GO:0001705 | 3 | 0.028 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.028 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.028 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.028 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.028 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.028 | |
| oviduct development | GO:0060066 | 3 | 0.028 | |
| regulation of b cell apoptotic process | GO:0002902 | 13 | 0.027 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.027 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.027 | |
| regulation of cell motility | GO:2000145 | 236 | 0.027 | |
| thymus development | GO:0048538 | 41 | 0.027 | |
| response to hypoxia | GO:0001666 | 58 | 0.027 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.027 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.027 | |
| regulation of secretion | GO:0051046 | 274 | 0.027 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.027 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.027 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.027 | |
| modification of morphology or physiology of other organism | GO:0035821 | 18 | 0.027 | |
| molting cycle | GO:0042303 | 90 | 0.026 | |
| regulation of mammary gland epithelial cell proliferation | GO:0033599 | 12 | 0.026 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.026 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.026 | |
| primary neural tube formation | GO:0014020 | 95 | 0.026 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.026 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.026 | |
| stem cell proliferation | GO:0072089 | 117 | 0.026 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.026 | |
| negative regulation of retinal cell programmed cell death | GO:0046671 | 2 | 0.026 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.026 | |
| modification of morphology or physiology of other organism involved in symbiotic interaction | GO:0051817 | 16 | 0.026 | |
| skin morphogenesis | GO:0043589 | 38 | 0.026 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.026 | |
| regulation of cell growth | GO:0001558 | 91 | 0.025 | |
| organelle fusion | GO:0048284 | 28 | 0.025 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.025 | |
| response to growth factor | GO:0070848 | 198 | 0.025 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.025 | |
| cell fate commitment | GO:0045165 | 210 | 0.025 | |
| carbon catabolite activation of transcription | GO:0045991 | 4 | 0.025 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.025 | |
| regulation of execution phase of apoptosis | GO:1900117 | 9 | 0.025 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.025 | |
| negative regulation of intrinsic apoptotic signaling pathway | GO:2001243 | 34 | 0.025 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.025 | |
| cell junction assembly | GO:0034329 | 52 | 0.025 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.025 | |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 34 | 0.025 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.025 | |
| positive regulation of striated muscle tissue development | GO:0045844 | 31 | 0.025 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.024 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.024 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.024 | |
| t cell lineage commitment | GO:0002360 | 13 | 0.024 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.024 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.024 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.024 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.024 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.024 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.024 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.024 | |
| positive regulation of neuron apoptotic process | GO:0043525 | 25 | 0.024 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.024 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.024 | |
| negative regulation of peptidyl serine phosphorylation | GO:0033137 | 10 | 0.024 | |
| protein localization to organelle | GO:0033365 | 185 | 0.024 | |
| tissue remodeling | GO:0048771 | 102 | 0.024 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.024 | |
| tube closure | GO:0060606 | 91 | 0.024 | |
| vesicle organization | GO:0016050 | 60 | 0.024 | |
| regulation of ion transport | GO:0043269 | 215 | 0.024 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.023 | |
| response to inorganic substance | GO:0010035 | 96 | 0.023 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.023 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.023 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.023 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.023 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.023 | |
| tube formation | GO:0035148 | 140 | 0.022 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.022 | |
| organelle localization | GO:0051640 | 179 | 0.022 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.022 | |
| mesenchyme development | GO:0060485 | 152 | 0.022 | |
| negative regulation of cysteine type endopeptidase activity | GO:2000117 | 22 | 0.022 | |
| regulation of fibroblast proliferation | GO:0048145 | 34 | 0.022 | |
| regionalization | GO:0003002 | 337 | 0.022 | |
| neuron maturation | GO:0042551 | 29 | 0.022 | |
| t cell homeostasis | GO:0043029 | 35 | 0.022 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.022 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.022 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.022 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.022 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.022 | |
| dna metabolic process | GO:0006259 | 303 | 0.021 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.021 | |
| interaction with host | GO:0051701 | 22 | 0.021 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.021 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.021 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.021 | |
| pigment metabolic process | GO:0042440 | 32 | 0.021 | |
| modulation by virus of host morphology or physiology | GO:0019048 | 3 | 0.021 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.021 | |
| epithelial tube formation | GO:0072175 | 130 | 0.021 | |
| peptide secretion | GO:0002790 | 114 | 0.021 | |
| cellular response to hypoxia | GO:0071456 | 17 | 0.021 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.021 | |
| oxidation reduction process | GO:0055114 | 342 | 0.021 | |
| establishment of protein localization to plasma membrane | GO:0090002 | 34 | 0.021 | |
